Verasonics Appoints New Senior Vice President, Research & Development
Verasonics Appoints New Senior Vice President, Research & Development
Verasonics, Inc. announced today the appointment of Richard Van Bibber, Ph.D., as senior vice president of research & development. In this role, Van Bibber will lead the company’s R&D organization and advance its innovation strategy for ultrasound research and product development.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260820558816/en/
Richard Van Bibber, Ph.D., newly appointed senior vice president of research & development at Verasonics. Van Bibber brings nearly 30 years of experience leading the development of innovative medical technologies, with a proven track record of bringing medical device products from concept through commercialization. Throughout his career, he has built and led high-performing engineering teams and driven the development of complex hardware and software solutions. Van Bibber holds a Ph.D. in Physiology and Biophysics from the University of Washington and a Bachelor of Science in Physiological Science from UCLA.
“I am pleased to welcome Rich to Verasonics,” said Jon K. Daigle, CEO of Verasonics. “His extensive experience in medical technology innovation, combined with his expertise in diagnostic ultrasound, makes him a valuable addition to our leadership team. Rich’s proven ability to lead the development of breakthrough technologies will help advance our mission of empowering ultrasound innovation worldwide.”
Van Bibber brings nearly 30 years of experience leading the development of innovative medical technologies, with a proven track record of bringing medical device products from concept through commercialization. Throughout his career, he has built and led high-performing engineering teams and driven the development of complex hardware and software solutions.
Most recently, Van Bibber served as Chief Technology Officer at Caeli Vascular and GenPrime, Inc., where he led product design, development, verification, and validation activities. He also brings experience with diagnostic ultrasound technologies, including TTE, TEE, ICE, and 3D echocardiography, with expertise spanning quantitative imaging, image-guided procedures, and advanced medical device development.
Van Bibber holds a Ph.D. in Physiology and Biophysics from the University of Washington and a Bachelor of Science in Physiological Science from UCLA.
About Verasonics, Inc.
Headquartered in Kirkland, Washington, USA, Verasonics is a privately held company founded in 2001. Verasonics, the leader in research ultrasound, empowers ultrasound innovation worldwide by providing flexible ultrasound platforms for research, development, and commercialization. Verasonics solutions are used across biomedical ultrasound, materials science, earth sciences, and acoustics to help accelerate innovation from concept to market. Verasonics also licenses its technology to companies for use in their commercial products.
Learn more by visiting the Verasonics website or following us on LinkedIn and X.
Media Contact:
Verasonics, Inc.
James Schada
T: 425-439-7235
E: jamesschada@verasonics.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20260820558816/en/
The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.
Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.
Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.
Popular
4 Stocks to Buy Before They Rise Further
2 Undervalued Stocks to Buy Before They Rebound
The 10 Best Dividend Stocks
12 Best Blue-Chip Stocks to Buy for the Long Term
United States